Vanguard Capital Management
GILD icon

Vanguard Capital Management’s Gilead Sciences GILD Stock Holding History

Vanguard Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2B Buy
81,091,734
+436,958
+0.5% +$57.6M 0.22% 75
2026
Q1 		$11.2B Buy
+80,654,776
New +$11.3B 0.28% 58

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Capital Management's GILD Position: Q2 2026 in Review

Vanguard Capital Management increased its Gilead Sciences (GILD) stake by 0.54% in Q2 2026, buying an estimated $57.6M and bringing the position to 81,091,734 shares worth $10.2B. The position accounts for 0.22% of the portfolio, ranked #75.

Vanguard Capital Management first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.2B in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vanguard Capital Management held 81,091,734 shares of Gilead Sciences worth $10.2B as of Q2 2026.
  • Vanguard Capital Management bought 436,958 Gilead Sciences shares in Q2 2026, an estimated $57.6M.
  • Gilead Sciences made up 0.22% of Vanguard Capital Management's portfolio in Q2 2026, its #75 holding.
  • Vanguard Capital Management first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Gilead Sciences position peaked at $11.2B in Q1 2026.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.